Parasitic Infections in HIV-Infected Patients

  • Authors: José M. Miró, MD, PhD; Miriam J. Álvarez-Martínez, MD, PhD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/20/21 (What's New)

Summary

  • Visceral leishmaniasis is characterized by fever, systemic malaise, weight loss, hepatosplenomegaly, lymphadenopathy, and pancytopenia
    • Atypical manifestations affecting the gastrointestinal tract, lungs, skin, and pleural and peritoneal cavities have been described in profoundly immunosuppressed patients
    • Relapse is common in visceral leishmaniasis/HIV coinfection[Alvar 2008]

Action required

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.